Elizabeth Luis

3.5k total citations
18 papers, 885 citations indexed

About

Elizabeth Luis is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elizabeth Luis has authored 18 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elizabeth Luis's work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Receptor Mechanisms and Signaling (3 papers). Elizabeth Luis is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Receptor Mechanisms and Signaling (3 papers). Elizabeth Luis collaborates with scholars based in United States, France and Japan. Elizabeth Luis's co-authors include Lino C. Gonzalez, Paul Polakis, Hartmut Koeppen, Sarajane Ross, Min Lu, Avi Ashkenazi, Xiaofen Ye, Scot A. Marsters, James C. Marsters and John T. Stults and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Elizabeth Luis

18 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Luis United States 15 497 275 271 160 112 18 885
Fook-Thean Lee Australia 19 449 0.9× 341 1.2× 400 1.5× 125 0.8× 47 0.4× 29 991
Brigid C. Browne Ireland 14 548 1.1× 570 2.1× 198 0.7× 30 0.2× 54 0.5× 22 969
Rong-Hua Tao United States 12 430 0.9× 152 0.6× 117 0.4× 118 0.7× 17 0.2× 17 648
Moshit Lindzen Israel 20 524 1.1× 393 1.4× 179 0.7× 13 0.1× 38 0.3× 32 889
Cédric Leroy France 13 524 1.1× 255 0.9× 41 0.2× 71 0.4× 13 0.1× 20 871
Philip Ryan United States 14 514 1.0× 159 0.6× 31 0.1× 30 0.2× 71 0.6× 23 824
David L. Shattuck United States 7 384 0.8× 365 1.3× 179 0.7× 21 0.1× 12 0.1× 9 695
Vadim Le Joncour Finland 15 296 0.6× 222 0.8× 175 0.6× 39 0.2× 17 0.2× 32 655
Ta‐Chun Yuan United States 10 378 0.8× 141 0.5× 66 0.2× 37 0.2× 29 0.3× 11 636
Renee Garcia‐Arenas United States 13 421 0.8× 166 0.6× 22 0.1× 93 0.6× 61 0.5× 13 703

Countries citing papers authored by Elizabeth Luis

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Luis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Luis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Luis more than expected).

Fields of papers citing papers by Elizabeth Luis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Luis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Luis. The network helps show where Elizabeth Luis may publish in the future.

Co-authorship network of co-authors of Elizabeth Luis

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Luis. A scholar is included among the top collaborators of Elizabeth Luis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Luis. Elizabeth Luis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Asundi, Jyoti, Lisa Crocker, Jarrod R. Tremayne, et al.. (2015). An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies. Clinical Cancer Research. 21(14). 3252–3262. 28 indexed citations
2.
Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models. Molecular Cancer Therapeutics. 13(11). 2630–2640. 52 indexed citations
3.
Lu, Min, Scot A. Marsters, Xiaofen Ye, et al.. (2014). E-Cadherin Couples Death Receptors to the Cytoskeleton to Regulate Apoptosis. Molecular Cell. 54(6). 987–998. 86 indexed citations
4.
Haddick, Patrick C. G., Irene Tom, Elizabeth Luis, et al.. (2014). Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor. PLoS ONE. 9(1). e84823–e84823. 40 indexed citations
5.
Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). Abstract 4494: A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers. Cancer Research. 74(19_Supplement). 4494–4494. 1 indexed citations
6.
Gupta, Nidhi, Willy A. Solis, Reina N. Fuji, et al.. (2014). Abstract 4502: Nonclinical characterization and tolerability of a surrogate anti-mesothelin-MMAE antibody-drug conjugate. Cancer Research. 74(19_Supplement). 4502–4502. 1 indexed citations
7.
Kauder, Steven E., Lydia Santell, Elaine Mai, et al.. (2013). Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele. PLoS ONE. 8(12). e83958–e83958. 17 indexed citations
8.
Mukund, Susmith, Holly J. Clarke, Azadeh Madjidi, et al.. (2013). Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor. Journal of Biological Chemistry. 288(50). 36168–36178. 33 indexed citations
9.
Scheer, Justin M., Wendy Sandoval, J. Michael Elliott, et al.. (2012). Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators. PLoS ONE. 7(12). e51817–e51817. 32 indexed citations
10.
Koth, Christopher M., Jeremy Murray, Susmith Mukund, et al.. (2012). Molecular basis for negative regulation of the glucagon receptor. Proceedings of the National Academy of Sciences. 109(36). 14393–14398. 103 indexed citations
11.
Asundi, Jyoti, Chae Reed, Krista McCutcheon, et al.. (2011). An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma. Clinical Cancer Research. 17(5). 965–975. 44 indexed citations
12.
Lobito, Adrian A., Sree R. Ramani, Irene Tom, et al.. (2011). Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1. Journal of Biological Chemistry. 286(21). 18969–18981. 35 indexed citations
13.
Tinianow, Jeff N., Herman Gill, Annie Ogasawara, et al.. (2010). Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET. Nuclear Medicine and Biology. 37(3). 289–297. 90 indexed citations
14.
Zha, Jiping, Carol O’Brien, Heidi Savage, et al.. (2009). Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer. Molecular Cancer Therapeutics. 8(8). 2110–2121. 66 indexed citations
15.
Chen, Youjun, Suzanna Clark, Terence Z. Wong, et al.. (2007). Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models. Cancer Research. 67(10). 4924–4932. 70 indexed citations
16.
Mao, Weiguang, Elizabeth Luis, Sarajane Ross, et al.. (2004). EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer. Cancer Research. 64(3). 781–788. 105 indexed citations
17.
Arnott, David, et al.. (2002). Selective Detection of Membrane Proteins Without Antibodies. Molecular & Cellular Proteomics. 1(2). 148–156. 71 indexed citations
18.
King, Kathleen L., Jane Winer, Elizabeth Luis, et al.. (1996). Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro. Endocrine. 5(1). 85–93. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fook-Thean Lee Breakdown of academic impact, for papers by Brigid C. Browne Breakdown of academic impact, for papers by Rong-Hua Tao Breakdown of academic impact, for papers by Moshit Lindzen Breakdown of academic impact, for papers by Cédric Leroy Breakdown of academic impact, for papers by Philip Ryan Breakdown of academic impact, for papers by David L. Shattuck Breakdown of academic impact, for papers by Vadim Le Joncour Breakdown of academic impact, for papers by Ta‐Chun Yuan Breakdown of academic impact, for papers by Renee Garcia‐Arenas
Rankless by CCL
2026